Bausch+Lomb IPO Presentation Deck

LUMIFYⓇ: #1 Brand in redness reliever category BAUSCH + LOMB LUMIFY BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.025% REDNESS RELIEVER EYE DROPS • Works in 1 minute • Lasts up to 8 hours Sterile BAUSCH LOMB LUMIFY MONIDINE TARTRATE OPHTHALMIC SOLUTION 0.95 RESMESS RELEVER EYE DROPS Balle BAUSCH + LOMB #1 #1 97% in Redness Reliever category with -50% market share¹ Physician- recommended product in the Redness Reliever category² Satisfaction rating in a recent in-home- use-study with 243 participants3 Expect to launch LUMIFYⓇ in several international markets and grow franchise through line extensions 1. IRI Panel Omnichannel as of 12-31-2021; trademarks are property of respective owners. 2. IQVIA ProVoice Survey Data Ending Q3 2021 3. Data Source: Lieberman, Lumify Brand Health Monito, October 2021. 4. See Slide 2 for further information about comparable information. 38% 28% 16% 11% 8% 0% 1Q17 % of Weekly Market Share in Redness Reliever Category1,4 3Q17 Lumify 1Q18 3Q18 Clear Eyes 1Q19 3Q19 Private Label CONSUMER HEALTH CARE 1Q20 Visine 3Q20 1Q21 Rohto 3Q21 50% 25% 11% 7% 5% 2% All Other 25

View entire presentation